Inventiva SA (IVA)
3.19
-0.13
(-3.92%)
USD |
NASDAQ |
Oct 09, 13:04
Inventiva Enterprise Value : 733.06M for Oct. 8, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 733.06M |
| October 07, 2026 | 743.69M |
| October 06, 2026 | 766.14M |
| October 05, 2026 | 770.87M |
| October 02, 2026 | 789.77M |
| October 01, 2026 | 766.14M |
| September 30, 2026 | 820.48M |
| September 29, 2026 | 725.97M |
| September 28, 2026 | 782.68M |
| September 25, 2026 | 744.87M |
| September 24, 2026 | 718.88M |
| September 23, 2026 | 763.78M |
| September 22, 2026 | 811.03M |
| September 21, 2026 | 811.03M |
| September 18, 2026 | 841.75M |
| September 17, 2026 | 834.66M |
| September 16, 2026 | 844.11M |
| September 15, 2026 | 860.65M |
| September 14, 2026 | 865.38M |
| September 11, 2026 | 898.46M |
| September 10, 2026 | 926.81M |
| September 09, 2026 | 1.000B |
| September 08, 2026 | 1.052B |
| September 04, 2026 | 1.078B |
| September 03, 2026 | 1.092B |
| Date | Value |
|---|---|
| September 02, 2026 | 1.097B |
| September 01, 2026 | 1.076B |
| August 31, 2026 | 1.054B |
| August 28, 2026 | 1.060B |
| August 27, 2026 | 1.106B |
| August 26, 2026 | 1.087B |
| August 25, 2026 | 1.057B |
| August 24, 2026 | 1.059B |
| August 21, 2026 | 1.054B |
| August 20, 2026 | 1.047B |
| August 19, 2026 | 1.073B |
| August 18, 2026 | 1.045B |
| August 17, 2026 | 1.059B |
| August 14, 2026 | 1.035B |
| August 13, 2026 | 1.035B |
| August 12, 2026 | 1.054B |
| August 11, 2026 | 1.064B |
| August 10, 2026 | 1.071B |
| August 07, 2026 | 1.083B |
| August 06, 2026 | 1.050B |
| August 05, 2026 | 1.064B |
| August 04, 2026 | 1.014B |
| August 03, 2026 | 952.80M |
| July 31, 2026 | 1.007B |
| July 30, 2026 | 1.040B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Nicox SA | -- |
| DBV Technologies SA | 352.30M |
| Cellectis SA | 63.31M |
| Genfit SA | -- |
| Innate Pharma SA | -- |
Enterprise Value Related Metrics
| Earnings Yield | -43.01% |
| Normalized Earnings Yield | -31.50 |